H.R. 5378
Passed SenateLower Costs, More Transparency Act
Latest Action
Motion to reconsider laid on the table Agreed to without objection.
12/11/2023 • House
Summary
Lower Costs, More Transparency Act
This bill requires health care providers and insurers to disclose certain information about health care costs. It also establishes requirements for certain payment methodologies under Medicare and Medicaid and extends several public health programs.
For example, the bill provides statutory authority for regulations that require hospitals to annually publish their prices and related information, including the discounted cash price and negotiated charges. The bill also specifically extends these requirements to clinical laboratories, imaging service providers, and ambulatory surgical centers that participate in Medicare. Additionally, pharmacy benefit managers (PBMs) must semiannually report to health plan sponsors certain information on spending, rebates, and fees that are associated with covered drugs. Contracts with PBMs for employer-sponsored health plans must also allow health plan fiduciaries to audit certain claims and cost information without undue restrictions.
In addition, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid. It also requires Medicare payments for certain drug administration services at off-campus hospital outpatient departments to be the same as that for other provider settings (i.e., physician offices).
The bill provides funds for the Department of Health and Human Services, the Department of Treasury, and the Department of Labor to implement and enforce the bill's requirements.
Finally, the bill extends several public health programs, including the Teaching Health Center Graduate Medical Education Program (through FY2030) and the National Health Service Corps (through December 31, 2025).
Passed House • 12/11/2023
Topics & Subjects
CBO Cost Estimates (2)
Estimated Direct Spending and Revenue Effects of H.R. 5378, the Lower Costs, More Transparency Act
As posted on the website of the Clerk of the House on September 13, 2023
Published: September 14, 2023
Estimated Direct Spending and Revenue Effects of H.R. 5378, the Lower Costs, More Transparency Act
As posted on the website of the Clerk of the House on December 5, 2023 https://tinyurl.com/h2vpjp8a
Published: December 8, 2023
Related Federal Spending
Sponsor & Cosponsors (4)
Party Breakdown
Sponsor
Cosponsors (3)
Bill Journey
Originated in the House
Introduced
September 8, 2023
Committee Review
Floor Debate
December 11, 2023
Passed Chamber
December 11, 2023
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 320 - 71, 1 Present (Roll no. 708). (text: CR H6762-6785)
Other Chamber
President
Enacted into Law
Text Versions (2)
Related Bills (10)
H.R. 4508
Hidden Fee Disclosure Act of 2023
H.R. 4527
Health DATA Act of 2023
H.R. 2665
Supporting Safety Net Hospitals Act
H.R. 3284
Providers and Payers COMPETE Act
H.R. 3839
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
H.R. 4883
Medicare Common Ownership Transparency Act of 2023
S. 775
Increasing Transparency in Generic Drug Applications Act
S. 1855
Special Diabetes Program Reauthorization Act of 2023
S. 2308
Community Health Care Reauthorization Act
H.R. 3237
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.